TuesdayJul 13, 2021 9:00 am

Sharing Services Global Corp. (SHRG) Strengthening Foothold as Industry Reports Record Sales Numbers

The direct-sales space reported $40.1 billion in retail sales last year, an increase of 13.9% from 2019 Successful direct-sales companies adapt quickly to a world with changing needs SHRG is working on multiple programs, expansion plans that will be unprecedented in the sector The United States saw record high sales, sellers and customers in the direct-sales sector in 2020, according to the industry’s leading national trade association (https://ibn.fm/aymKA). That news bodes well for Sharing Services Global (OTCQB: SHRG), a publicly traded company specializing in the direct-sales sector.  In its annual Growth & Outlook Study, the U.S. Direct Selling Association (“DSA”)…

Continue Reading

TuesdayJul 13, 2021 9:00 am

Rock-Solid Business Model, String of Big Box Contracts Point to Another Record-Breaking Year For Sustainable Green Team, Ltd. (SGTM)

SGTM transforms storm, hurricane waste into environmentally beneficial products that enhance, fortify the earth Company on solid growth trajectory with string of lucrative contracts awarded in recent months Clients include municipal governments, large commercial retailers including The Kroger Co, Circle K, Menards Inc. & Old Castle Lawn & Garden 2020 was record-breaking year, Q1-2021 results include QoQ increases of 16.7% in revenue and 8.6% in gross profit Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, is on a growth trajectory with a lucrative string of large commercial contracts, a rock-solid…

Continue Reading

MondayJul 12, 2021 1:13 pm

HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Completes Acquisition of Sagely Naturals as it Eyes Continued Growth in 2021 and Beyond

HempFusion Wellness closed the acquisition of Sagely Naturals, a women-centric CBD company, for an initial consideration of US$25 million in cash and stock payments The acquisition is expected to benefit both parties in various ways, including by increasing HempFusion’s revenue and providing access to Sagely’s extensive distribution footprint On its part, Sagely will benefit from HempFusion’s regulatory compliance, which will help in the introduction of ingestible CBD products HempFusion is looking forward to driving shareholder value through continued growth both domestically and internationally with its expanding family of brands In fulfillment of a merger agreement announced in late May, Denver-based…

Continue Reading

MondayJul 12, 2021 1:03 pm

Q1 Productions’ 2nd Annual Medical Device Biocompatibility & Toxicology Risk Assessment Conference To Offer Safe Medical Testing Strategies For Commercial Markets

Date: July 21-23, 2021  Virtual Event Companies and professionals from the biocompatibility, toxicology, materials engineering, and related medical fields are invited to attend the Q1 Productions’ 2nd Annual Medical Device Biocompatibility & Toxicology Risk Assessment Conference being held on July 21-23, 2021. Industry leaders and regulatory authorities will share presentations discussing compliant design and commercialization evaluation processes for medical device professionals to develop safe testing strategies. This online streaming conference is a great opportunity for you to meet and collaborate with industry professionals to ensure your products meet biological safety requirements as per the global safety standards. The event will…

Continue Reading

MondayJul 12, 2021 12:31 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Marks Major Milestone for its Rapid Point-Of-Care Diagnostic Business Strategy

XPhyto began delivery of approximately 1,000 Covid-ID Lab test kits in Berlin This marks a significant achievement commercially, as well as for the company’s point-of-care diagnostic business strategy The lab tests are designed to offer reliable Covid-19 test results in under 25 minutes XPhyto plans to capitalize on the rapid test market, projected to reach $39.1 billion by 2023 For the week starting June 27, 2021, XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) began delivery of approximately 1,000 Covid-ID Lab test kits to 10 different test centers in Berlin, Germany. This move is a major commercial achievement for the…

Continue Reading

MondayJul 12, 2021 12:20 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Is ‘One to Watch’

Avricore Health Inc. is a pharmacy solutions provider that combines best-in-class point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues The company’s wholly owned subsidiary, HealthTab, offers fast, accurate and cost-effective point-of-care screening Its current test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR); HealthTab has also recently added capabilities for bacterial and viral tests, such as strep and COVID-19 The company leverages strategic partnerships with notable names in the diagnostic space, including Abbott Rapid Diagnostics, to offer high quality,…

Continue Reading

MondayJul 12, 2021 12:06 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Eyes Bright Future in Big Data Insights

FingerMotion (OTCQX: FNGR) is anticipating significant growth in mobile service sales during the coming year. “The company’s focus on rich communication services (‘RCS’) and data insights in China’s huge marketplace for mobile products has positioned the U.S.-based company for growth in the insuratech industry, particularly, where it anticipates acquiring service for more than a billion customers in the Southeast Asian Nation,” reads a recent article. The company is leveraging partnerships to build a communications ecosystem of active users of its innovative applications and expects to develop access to users’ data to strengthen its Sapientus database IP. Sapientus has already led…

Continue Reading

MondayJul 12, 2021 11:50 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) Delivering on Vision of AR, Immersive Learning to Transform Higher Education

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a provider of virtual and augmented reality (“AR”) experience technologies and services for e-commerce, education, advertising, conferences, and events, jointly received government funding of up to $150,000 alongside Ryerson University. The amount, awarded by the Virtual Learning Strategy’s eCampusOntario (an initiative of the Ontario Ministry of Colleges and Universities), was in recognition for the partners’ efforts in creating and delivering AR learning experiences within the postsecondary education sector. A recent article quotes Nextech CEO Evan Gappelberg as saying, “With the help of the Ontario Government — who shares our vision of…

Continue Reading

MondayJul 12, 2021 11:42 am

QualityStocksNewsBreaks – Emaginos Inc.’s DLS Model Meets Needs of K-12 Students Searching for Effective Ways to Learn

Emaginos, a REG-A public company (please see website if interested in investing) in the business of transforming K-12 public education, has built a Discovery and Learning System (“DLS”) that perfectly meets the demands exposed by the pandemic. Through its model, the company is prepared for the changes that the global pandemic has forced upon a generation of K-12 students struggling to find the most effective way to learn. But, as Emaginos President Allan Jones noted in an open letter to educators, “COVID did not create the need… The Emaginos Model was an idea in search of its time.” A recent…

Continue Reading

MondayJul 12, 2021 11:17 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delists from CSE to Focus Efforts on Most Effective Drug Platform Outcomes

Lexaria Bioscience is a drug bioavailability platform developer intent on providing an effective oral administration alternative to smoking that duplicates the rapid assimilation benefits of inhalation without the lung-harmful effects The company’s DehydraTECH IP is being evaluated for concentration levels, tolerability and ability to transform partner drugs to oral solutions without incidentally creating new molecular entities Lexaria announced voluntary delisting from the Canadian Securities Exchange this month in order to focus its resources more effectively on its Nasdaq listing The company’s leadership recently interacted with investors in the Life Sciences Investor Forum virtual conference series and the company’s annual meeting…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered